Siegfried opens new global R&D Center for Drug Substances in Evionnaz

New facility to drive development excellence and further growth

21-Nov-2024 - Siegfried inaugurated its new global Research and Development (R&D) Center for Drug Substances at its site in Evionnaz, Switzerland. The 4,500m2 R&D Center houses advanced chemical and analytical facilities, state-of-the-art laboratories, and cutting-edge technologies such as flow chemistry, ...

Siegfried begins construction of new large-scale production plant in Minden (DE)

Total investment of up to CHF 100 million

26-Aug-2022 - Siegfried broke ground and celebrated the start of the construction of its new large-scale production plant in Minden, Germany. The planned production plant, for which Siegfried will invest up to CHF 100 million, is the largest building project in the company's history. The new facility, which is ...

Siegfried: Closing conditions for acquisition of three BASF sites satisfied

22-Sep-2015 - All closing conditions on the path toward Siegfried‘s acquisition of BASF’s pharmaceutical supply business have been fulfilled. They include regulatory assurance issued by Swissmedic that the necessary approval for the Evionnaz production site will be provided in time for the closing. Siegfried ...

Siegfried plans production plant in Nantong, China

06-Jul-2012 - Siegfried plans the erection of a production plant in Nantong, China, supported by NETDA, a Chinese development organization. The development of production capacity in China will strengthen Siegfried’s competitive position and create additional sales opportunities in Asia. The company is ...

Siegfried reports distinct sales increase for first 3 quarters of 2010

29-Oct-2010 - The Siegfried Group reports sales of CHF 218.5 million for the first 9 months of the 2010 financial year, representing an increase of 8.8% in Swiss francs and of 12.1% in local currencies over the comparable period the previous year. Siegfried sold active pharmaceutical ingredients and ...

Siegfried (USA) Inc. and Jazz Pharmaceuticals sign Supply Agreement

31-May-2010 - Siegfried (USA) Inc announced that on April 1, 2010, a Supply Agreement with Jazz Pharmaceuticals Inc. was executed. Siegfried has the right to supply at least 60% of Jazz Pharmaceutical’s worldwide requirements of sodium oxybate, the active pharmaceutical ingredient in Xyrem® (sodium oxybate) ...

Siegfried to introduce functional organization

03-Feb-2010 - Effective March 1, 2010, the Siegfried Group will introduce a functional organization to replace its current two-division structure. The new structure is a result of strategic adjustments approved in the summer of 2009. Siegfried will increasingly market its two core capabilities, namely the ...

Siegfried signs comprehensive cooperation agreement with Arena Pharmaceuticals

20-Dec-2007 - Siegfried has signed long-term cooperation agreements with Arena Pharmaceuticals, Inc. Under the agreement, primarily the active pharmaceutical ingredient (API) for Arena's drug Lorcaserin hydrochloride and other APIs will be produced at the Siegfried plant in Zofingen. For the production of its ...